Recombinant Anti-CD33 x Anti-DENV Bispecific Antibody (VHH-IgG) (BSSG-390)

Recombinant Anti-CD33 x Anti-DENV Bispecific Antibody (VHH-IgG) is formed by an IgG and two VHH fragments. The VHHs from an anti-DENV antibody variable domain are respectively connected to the N terminus of the anti-CD33 IgG heavy chains or light chains to form VHH-(H)IgG or VHH-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb is designed for the research of antibody-dependent enhancement (ADE) and dengue virus infection.

Datasheet INQUIRY

Specifications

Targets

CD33 & DENV

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS

Related Disease

Dengue virus infection

Targets

Target 1

CD33

Gene ID

945

UniProt ID

P20138

Alternative Names

CD33; CD33 molecule; Cluster of differentiation 33; p67; SIGLEC3; SIGLEC-3; myeloid cell surface antigen CD33; gp67; CD33 antigen (gp67); sialic acid binding Ig-like lectin 3; sialic acid-binding Ig-like lectin 3

Target 2

DENV

Alternative Names

dengue virus; DENV; dengue fever; Flavivirus

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD33 x Anti-DENV Bispecific Antibody (VHH-IgG) (BSSG-390). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD33 x Anti-DENV Bispecific Antibody (VHH-IgG) (CAT#: BSSG-390)

Specifications

Targets

Customer Reviews and Q&As